Journal Article

Autosomal Recessive Familial Neurohypophyseal Diabetes Insipidus with Continued Secretion of Mutant Weakly Active Vasopressin

Michael D. Willcutts, Eric Felner and Perrin C. White

in Human Molecular Genetics

Volume 8, issue 7, pages 1303-1307
Published in print July 1999 | ISSN: 0964-6906
Published online July 1999 | e-ISSN: 1460-2083 | DOI: http://dx.doi.org/10.1093/hmg/8.7.1303
Autosomal Recessive Familial Neurohypophyseal Diabetes Insipidus with Continued Secretion of Mutant Weakly Active Vasopressin

Show Summary Details

Preview

Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by postnatal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene. All published mutations affect the signal peptide or the neu-rophysin-II carrier protein and are presumed to interfere with processing of the preprohormone, leading to neuronal damage. We studied an unusual Palestinian family consisting of asymptomatic first cousin parents and three children affected with neu-rohypophyseal diabetes insipidus, suggesting auto-somal recessive inheritance. All three affected children were homozygous and the parents heterozygous fora single novel mutation (C301→T) in exon 1, replacing Pro7 of mature AVP with Leu (Leu-AVP). Leu-AVP was a weak agonist with ∼30-fold reduced binding to the human V2 receptor. Measured by radioimmunoassay with a synthetic Leu-AVP standard, serum Leu-AVP levels were elevated in all three children and further increased during water deprivation to as high as 30 times normal. The youngest child (2 years old) was only mildly affected but had Leu-AVP levels similar to her severely affected 8-year-old brother, suggesting that unknown mechanisms may partially compensate for a deficiency of active AVP in very young children.

Journal Article.  3015 words.  Illustrated.

Subjects: Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.